Year: 2025
Type: article
Abstract: Drug resistance in bacteria and fungi is a global threat to public health. The purpose of this publication is to review the latest scientific achievements, mainly from 2020-2025, concerning the use of hemp compounds from Cannabis sativa in combating drug-resistant bacterial and fungal infections. The literature review confirms that C.sativa, a plant with a documented centuries-old therapeutic history, is a rich source of cannabinoids and terpenes that combat drug-resistant bacteria: Mycobacterium tuberculosis, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and fungi: Cryptococcus neoformans, as well as species from the Candida and Aspergillus. The potential of hemp compounds is based on their activity in interacting directly with pathogens by disrupting cell membrane integrity, eradicating biofilm, having a bactericidal effect on bacterial spores, acting synergistically, affecting host inflammatory pathways, and the human endocannabinoid system.
Source: Folia Medica Cracoviensia
Author: Sabina Gałka
Institution: Medical University of Silesia
Language: Polish
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: Cannabis sativa, cannabinoids, terpenes, antimicrobial resistance, drug-resistant bacteria, drug-resistant fungi, Mycobacterium tuberculosis, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, Cryptococcus neoformans, Candida, Aspergillus, biofilm eradication, endocannabinoid system, plasma membrane integrity
Open Access status: bronze
OpenAlex ID: W7126088023
